ETV6 /FLT3 fusion in a mixed-phenotype acute leukemia arising in lymph nodes in a patient with myeloproliferative neoplasm with eosinophilia
Autor: | Joseph M. Brandwein, Niloufar Hosseini, Denis Bailey, Shabnam Salehi-Rad, Shawn Brennan, Kenneth J. Craddock, Anna Porwit |
---|---|
Rok vydání: | 2014 |
Předmět: |
Acute leukemia
Pathology medicine.medical_specialty Histology Myeloid medicine.diagnostic_test business.industry Lymph node biopsy hemic and immune systems Hematology medicine.disease Peripheral T-cell lymphoma Pathology and Forensic Medicine ETV6 fluids and secretions medicine.anatomical_structure Myeloproliferative Disorders hemic and lymphatic diseases embryonic structures medicine Cancer research Eosinophilia medicine.symptom business Myeloproliferative neoplasm |
Zdroj: | Journal of Hematopathology. 7:71-77 |
ISSN: | 1865-5785 1868-9256 |
DOI: | 10.1007/s12308-014-0203-6 |
Popis: | The ETV6/FLT3 fusion gene has been recently reported in association with myeloproliferative neoplasm with eosinophilia (MPN-Eo) and peripheral T cell lymphoma. Favorable clinical response to a targeted FLT3 tyrosine kinase inhibitor (FLT3 TKI) was noted. Here we report a novel phenotype associated with ETV6/FLT3 rearrangement, in a 38-year-old female with presentation of progressive lymphadenopathy. Lymph node biopsy showed mixed-phenotype acute leukemia (MPAL) with expression of T cell and myeloid markers. Bone marrow morphology was consistent with MPN-Eo and no evidence of MPAL. Karyotype analysis revealed 46, XX, t(12;13)(p13;q12). ETV6/FLT3 fusion was demonstrated by fluorescence in situ hybridization. This is the first report of ETV6/FLT3 rearrangement showing a phenotype of extramedullary T/myeloid MPAL arising in the setting of MPN-Eo. We suggest addition of this entity to the WHO category of “myeloid/lymphoid neoplasms with eosinophilia,” particularly given the possibility of clinical response to FLT3 TKI in MPAL, a disease usually associated with poor prognosis. |
Databáze: | OpenAIRE |
Externí odkaz: |